SOCSI methylation in patients with newly diagnosed acute myeloid leukemia

Genes Chromosomes and Cancer

Volumn 37, Issue 3, 2003, Pages 300-305

  Chen, Chien Yuan ^a   Tsay, Woei ^a   Tang, Jih Luh ^a   Shen, Hwei Ling ^a   Lin, Shu Wha ^a   Huang, Sheng Yi ^a   Yao, Ming ^a   Chen, Yao Chang ^a   Shen, Ming Ching ^a   Wang, Chiu Hwa ^a   Tien, Hwei Fang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; JANUS KINASE; STAT PROTEIN; SUPPRESSOR FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG; CARRIER PROTEIN; REPRESSOR PROTEIN; SIGNAL PEPTIDE; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; CYTOGENETICS; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE FREQUENCY; GENE SILENCING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PARAMETER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; PROTEIN METHYLATION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSCRIPTION REGULATION; BONE MARROW CELL; CHEMISTRY; CHROMOSOME ANALYSIS; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

JANUS;

BONE MARROW CELLS; CARRIER PROTEINS; CYTOGENETIC ANALYSIS; DNA METHYLATION; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; REPRESSOR PROTEINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TREATMENT OUTCOME;

EID: 0038546657     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10222     Document Type: Article

References (37)

1. Arnould C, Philippe C, Bourdon V, Grégoire MJ, Berger R, Jonveaux P. 1999. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoid receptor alpha in acute promyelocytic-like leukemia. Hum Mol Genet 8:1741-1749.
2. Benekli M, Xia Z, Donohue KA, Ford LA, Pixley LA, Baer MR, Baumann H, Wetzler M. 2002. Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease free survival. Blood 99:252-257.
3. Bird AP. 1986. CpG-rich islands and the function of DNA methylation. Nature 321:209-213.
4. Bowman T, Garcia R, Turkson J, Jove R. 2000. STATs in oncogenesis. Oncogene 19:2474-2488.
5. INK4B CpG-island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 94:2445-2451.
6. Coffer PJ, Koenderman L, de Groot RP. 2000. The role of STATs in myeloid differentiation and leukemia. Oncogene 19:2511-2522.
7. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. 1997. A new protein containing an SH2 domain that inhibits JAK kinase. Nature 387:921-924.
8. Faderl S, Kantarjian HM, Estey E, Manshouri T, Chan CY, Rahman Elsaied A, Kornblau SM, Cortes J, Thomas DA, Pierce S, Keating MJ, Estrov Z, Albitar M. 2000. The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia. Cancer 89:1976-1982.
9. Frantsve J, Schwaller J, Sternberg DW, Kutock J, Gilliland DG. 2001. SOCS-1 inhibits TEL-JAK2 mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol Cell Biol 21:3547-3557.
10. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. 1996. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821-9826.
11. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Wilson TA, Spring NS, Starr R, Nicholson SE, Metcalf D, Nicola NA. 1998. Twenty proteins containing a C-terminal SOCS box from five structural classes. Proc Natl Acad Sci USA 95:114-119.
12. Huang SY, Tang JL, Liang YJ, Wang CH, Chen YC, Tien HF. 1997. Clinical, hematological and molecular studies in patients with chromosome translocation t(7;11): a study of four Chinese patients in Taiwan. Br J Haematol 96:682-687.
13. Issa JP, Baylin SB, Herman JG. 1997a. DNA methylation changes in hematologic malignancies: biological and clinical implications. Leukemia 11:s7-s11.
14. Issa JP, Zehnbauer BA, Kaufmann SH, Biel MA, Baylin SB. 1997b. HIC1 methylation is a late event in hematopoietic neoplasms. Cancer Res 57:1678-1681.
15. John RM, Paul CV, Susan JC. 1999. Concurrent DNA methylation of multiple genes in acute myeloid leukemia. Cancer Res 59:3730-3740.
16. Krebs DL, Hilton DJ. 2001. SOCS proteins: negative regulator of cytokine signaling. Stem Cells 19:378-387.
17. Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OA. 1997. A TEL-Jak2 fusion protein with constitutive kinase activity in human leukemia. Science 278:1309-1312.
18. Li Q, Kopecky KJ, Mohan A, Willman CL, Appelbaum FR, Weick JK, Issa JP. 1995. Estrogen receptor methylation is associated with improved survival in adult myeloid leukemia. Clin Cancer Res 5:1077-1084.
19. Lin TS, Mahajan S, Frank DA. 2000. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene 19:2496-2504.
20. Lotem J, Sachs L. 2002. Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene 21:3284-3294.
21. Mitelman F, editor. 1995. ISCN: an international system for human cytogenetic nomenclature. Basel: S. Karger.
22. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T. 1997. Structure and function of a new STAT induced STAT inhibitor. Nature 387:924-929.
23. O'shea JJ, Gadina M, Schreiber RD. 2002. Cytokine signaling in 2002: new surprises in the Jat/Stat pathway. Cell 109:S121-S131.
24. Plass C, Yu F, Yu L, Strout MP, El-Rifai W, Elonen E, Knuutila S, Marcucci G, Young DC, Held WA, Bloomfield CD, Caligiuri MA. 1999. Restriction landmark genome scanning for aberrant mehylation in primary refractory and relapsed acute myeloid leukemia: involvement of the WIT-1 gene. Oncogene 18:3159-3165.
25. Ravandi F, Talpaz M, Kantarjian H, Estrov Z. 2002. Cellular signaling pathways: new targets in leukemia therapy. Br J Haematol 116:57-77.
26. Rottapel R, Ilangumaran S, Neale C, La Rose J, Ho JM, Nguyen MH, Barber D, Dubrenil P, deSepulveda P. 2002. The tumor suppressor activity of SOCS-1. Oncogene 21:4351-4362.
27. Singal R, Ginder GD. 1999. DNA methylation. Blood 93:4059-4070.
28. Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F. 2001. Constitutive activation of STAT transcription factors in acute myelogenous leukemia. Eur J Hematol 67:63-71.
29. Spiekermann K, Pau M, Schwab R, Schmieja K, Franzrahe S, Hiddemann W. 2002. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells. Exp Hematol 30:262-271.
30. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. 1997. A family of cytokine-inducible inhibitors of signaling. Nature 387:917-921.
31. Starr R, Metcalf D, Elefanty AG, Brysha M, Willson TA, Nicola NA, Hilton DJ, Alexander WS. 1998. Liver degeneration and lymphoid deficiencies in mice lacking suppressor cytokine signaling-1. Proc Natl Acad Sci USA 95:14395-14399.
32. Suzuki R, Sakamoto H, Yasukawa H, Masuhara M, Wakioka T, Sasaki A, Yuge K, Komiya S, Inoue A, Yoshimura A. 1998. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT 3 activation in M1 leukemia cells. Oncogene 17:2271-2278.
33. Tien HF, Wang CH, Chen YC, Shen MC, Lin DT, Lin KH. 1993. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML. Leukemia 7:688-695.
34. Tien HF, Wang CH, Lin MT, Lee FY, Liu MC, Chuang SM, Chen YC, Shen MC, Lin KH, Lin DT. 1995. Correlation of cytogenetic results with immunophenotype, genotype, clinical features and ras mutation in acute myeloid leukemia. A study of 235 Chinese patients in Taiwan. Cancer Genet Cytogenet 84:60-68.
35. Tien HF, Tang JL, Tsay W, Liu MC, Lee FY, Wang CH, Chen YC, Shen MC. 2001. Methylation of the p15 (INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukemic transformation. Br J Haematol 112:148-154.
36. Wong IH, Ng MH, Huang DP, Lee JC. 2000. Aberrant p15 promotor methylation in adult and childhood acute leukemia of nearly all morphologic subtypes: potential prognostic implications. Blood 95:1942-1949.
37. Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG. 2001. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activitv. Nat Genet 28:29-35.